Targeting Aβ and Tau in Alzheimer's Disease, an Early Interim Report

Experimental Neurology - United States
doi 10.1016/j.expneurol.2009.07.035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in Physiology and Pathology

Frontiers in Neuroanatomy
AnatomyNeuroscienceCellularMolecular Neuroscience
2016English

Acetylated Tau in Alzheimer's Disease: An Instigator of Synaptic Dysfunction Underlying Memory Loss

BioEssays
BiochemistryGeneticsMolecular Biology
2017English

Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model

Journal of Neuroscience
Neuroscience
2017English

High-Contrast In-Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies

2020English

Cerebrospinal Fluid Tau and Phosphotau as Biomarkers in Alzheimer's Disease Diagnosis

Basic and Clinical Neuroscience
Molecular NeuroscienceNeurologyCellular
2019English

Early Onset Alzheimer's Disease

MOJ Gerontology & Geriatrics
2018English

Targeting S100B in Cerebral Ischemia and in Alzheimer's Disease

Cardiovascular Psychiatry and Neurology
PsychiatryMental HealthNeurologyCardiovascular MedicineCardiology
2010English

X11α Haploinsufficiency Enhances Aβ Amyloid Deposition in Alzheimer's Disease Transgenic Mice

Neurobiology of Disease
Neurology
2009English

Imaging Tau, Neuroinflammation and Aβ in Dementia With Lewy Bodies: A Deep-Phenotyping Case-Report

Movement Disorders Clinical Practice
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy